Biocomp Pharma is a company that manufactures carbinoxamine maleate. Carbinoxamine maleate is an antihistamine medication used to treat symptoms of the common cold and allergies, such as runny nose, sneezing, itchy eyes, and watery eyes [1]. It is available in various dosage forms, including tablets and oral solutions [1].
What is carbinoxamine maleate used for?
Carbinoxamine maleate is an H1 antagonist that works by blocking the action of histamine, a substance in the body that causes allergic symptoms [1]. It is prescribed for the relief of nasal and non-nasal symptoms of allergic rhinitis [2].
How is carbinoxamine maleate administered?
Carbinoxamine maleate can be taken orally. Dosage and frequency depend on the patient's age and the severity of their symptoms, and it is typically recommended to follow a doctor's prescription or the instructions on the product label [1].
What are potential side effects of carbinoxamine maleate?
Common side effects associated with carbinoxamine maleate include drowsiness, dizziness, dry mouth, blurred vision, and thickening of bronchial secretions [1]. Less common side effects may involve nausea, vomiting, or constipation [1]. Patients should consult their healthcare provider if they experience any persistent or bothersome side effects [1].
Are there alternatives to carbinoxamine maleate?
Other antihistamines are available for treating allergy and cold symptoms, including both first-generation and second-generation options. Second-generation antihistamines are generally associated with less drowsiness than first-generation drugs like carbinoxamine maleate [3].
Where can I find more information about carbinoxamine maleate?
Information regarding the patents, regulatory status, and clinical data for carbinoxamine maleate and its manufacturers, such as Biocomp Pharma, can be found on resources like DrugPatentWatch.com [4].
Sources
1. https://www.drugpatentwatch.com/drugs/carbinoxamine-maleate
2. https://www.drugpatentwatch.com/brands/biocomp-pharma-carbinoxamine-maleate
3. https://www.drugpatentwatch.com/drug-class/antihistamines
4. https://www.drugpatentwatch.com/